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OBJECTIVES This study aimed to evaluate the effect of primary angioplasty (PA) over the risk of free wall
rupture (FWR) in reperfused acute myocardial infarction (AMI).
BACKGROUND It has been suggested that PA reduces the risk of FWR compared with thrombolysis.
However, few studies have evaluated this issue, and there are no data demonstrating this
hypothesis.
METHODS A total of 1,375 patients with AMI treated with PA (n  762, 55.4%) or thrombolysis (n 
613, 44.6%) within 12 h after symptoms onset were included. The diagnosis of FWR was
made either in the presence of sudden death due to electromechanical dissociation with large
pericardial effusion on an echocardiogram or when demonstrated post mortem or at surgery.
A multivariable analysis was performed including type of reperfusion strategy.
RESULTS The overall incidence of FWR was 2.5% (n  34): 1.8% and 3.3% in patients treated with
PA and with thrombolysis, respectively (p  0.686). The following characteristics were
associated with a higher rate of FWR in the univariable analysis: age70 (5.2% vs. 1.2%, p
0.001), female gender (5.1% vs. 1.8%, p  0.006), anterior location (3.3% vs. 1.4%, p 
0.020) and treatment 2 h after symptoms onset (3.6% vs. 1.7%, p  0.043). In the
multivariable analysis, age 70 (odds ratio [OR]: 4.12, 95% confidence interval [CI]: 2.04 to
8.62, p  0.001) and anterior location (OR: 2.91, 95% CI: 1.36 to 6.63, p  0.008) were
independent risk factors of FWR, whereas treatment with PA was an independent protective
factor (OR: 0.46, 95% CI: 0.22 to 0.96, p  0.0371).
CONCLUSIONS In patients with AMI, PA reduces the risk of FWR in comparison with
thrombolysis. (J Am Coll Cardiol 2002;39:598–603) © 2002 by the American College of
Cardiology
Primary angioplasty (PA) is the preferred treatment for
acute myocardial infarction (AMI) in centers with available
infrastructure and well-trained personnel (1). The main
advantage of PA over thrombolysis is the achievement of a
higher rate of coronary recanalization with a lower risk of
intracranial bleeding (2–4).
Left ventricular free wall rupture (FWR) is the second
leading cause of in-hospital mortality in patients with AMI
(5,6). Some authors have suggested that PA reduces and
even avoids the risk of FWR, especially when a successful
angiographic result is obtained (7–9). However, few studies
have assessed this issue, and there are no data demonstrating
a reduction of the risk of FWR achieved by PA. The
objective of this study was to evaluate the possible effect of
PA in comparison with thrombolysis on the risk of FWR in
a consecutive series of patients with AMI reperfused with
either PA or with thrombolysis.
METHODS
Study population and criteria for referring patients to PA
or thrombolysis. A total of 1,413 consecutive patients with
AMI that were reperfused with either thrombolysis or PA
within 12 h after symptoms onset at our institution were
retrospectively studied. At our institution, patients that are
admitted with the diagnosis of AMI enter a prospective
database. The coronary care unit cardiologists are responsi-
ble for data entry, quality control, management and analysis.
Patients with hypotension (systolic blood pressure 90 mm
Hg) of uncertain origin and those having suffered syncope
underwent a routine transthoracic echocardiographic study
in order to rule out mechanical complications before begin-
ning treatment with thrombolysis or PA. Patients in whom
FWR was diagnosed before the reperfusion strategy were
not included in the study. Thirty-eight patients underwent
rescue angioplasty after failed thrombolysis and were ex-
cluded from the study. The remaining 1,375 patients
constitute the study population, 613 of whom (44.6%) were
treated with thrombolysis, and 762 (55.4%) with PA. The
initial 590 patients included in the cohort of patients treated
with PA are included in a previous publication (10).
The criteria for referring patients for thrombolysis or PA
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have varied over the years, depending on the period of time.
When participating in Global Use of Strategies to Open
Occluded Coronary Arteries (GUSTO) IIb angiographic
substudy (11) or in our single-center anterior location AMI
study (4), patients were randomly assigned to thrombolysis
or PA. When participating in the Primary Angioplasty in
Myocardial Infarction (PAMI) II (12), PAMI Stent Pilot
study (13), PAMI III (14) and Controlled Abciximab and
Device Investigation to Lower Late Angioplasty Compli-
cations (CADILLAC) clinical trials, all patients fulfilling
inclusion criteria were treated with primary PTCA. When
participating in Intravenous nPA for Treatment of Infarct-
ing Myocardium Early (INTIME) I and II studies (15), all
patients fulfilling inclusion criteria were treated with throm-
bolysis. Patients with contraindications for thrombolysis
were treated with PA, and those with anterior location or
cardiogenic shock were preferably treated with PA during
the entire period of study.
Definitions. The diagnosis of FWR was made in either of
the following situations: 1) sudden death occurred due to
electromechanical dissociation associated with large pericar-
dial effusion on an echocardiogram; or 2) FWR was iden-
tified post mortem or at surgery (16). Two patients treated
with PA and one patient treated with unsuccessful throm-
bolysis and subsequent rescue angioplasty (excluded from
the final study population) suffered coronary perforation
during PA and were not considered as having FWR. Free
wall rupture was defined as acute when it clinically pre-
sented as sudden death due to electromechanical dissocia-
tion, whereas it was considered subacute in the remaining
cases.
The status on coronary risk factors was coded according
to patients’ previously known histories. Patients were con-
sidered to have diabetes if they had been previously diag-
nosed by another physician or if they were being treated
with either insulin or oral antidiabetic drugs. Patients were
considered to have hypertension if they had been previously
diagnosed by another physician or if they were receiving
antihypertensive drugs.
Time (hours) to symptom onset was defined as the time
from the onset of symptoms to the starting of the reperfu-
sion strategy (either the administration of lytic or the
referral of the patient to the cath lab).
Thrombolysis, PA performance and medications admin-
istered. All patients received aspirin 300 to 500 mg in the
absence of contraindications.
Recombinant tissue plasminogen activator was the
thrombolytic agent in 458 patients (74.7%), streptokinase in
101 (16.5%), anisoylated streptokinase plasminogen activa-
tor complex in 16 (2.6%) and urokinase in 6 (1.0%). The
remaining 32 patients were included in the INTIME I and
II studies, which randomized patients with AMI to receive
tissue plasminigen activator or lanoteplase (15). When rtPA
was administered, a continuous intravenous infusion of
heparin was prescribed for 24 h in order to maintain a
partial thromboplastin time of 60 to 90 s, but routine
anticoagulation was not indicated when other thrombolytics
were used.
Primary angioplasty was performed by femoral approach
(6F to 8F catheter). In patients with multivessel disease,
only the infarct artery was treated, in the absence of
hemodynamic instability, persistent ischemia or inability to
identify the infarct vessel (17). Heparin 10,000 IU was
administered at the beginning of the procedure, and addi-
tional boluses were given if necessary to maintain an
activated clotting time 300 s (200 s in patients in whom
glycoprotein IIb/IIIa inhibitors were administered). Glyco-
protein IIb/IIIa inhibitors (Abciximab, Reopro, Lilly, Cen-
tocor B.V., Leiden, The Netherlands) were administered in
84 (11.0%) patients treated with PA, but it was not
administered in patients treated with thrombolysis. Coro-
nary stents were used in accordance with interventional
cardiologists’ criteria in patients not included in the PAMI
Stent Pilot, PAMI III and CADILLAC trials, and they
were placed in 426 (55.7%). Interventional cardiologists’
criteria have been modified over the years. Although during
the first years, a coronary stent was placed mainly in the
absence of a suboptimal result after balloon dilation, since
1995 there has been an increase in the frequency of elective
stenting in the setting of AMI (18).
Statistical analysis. Normally distributed continuous vari-
ables are expressed as mean  SD and compared by the
Student t test. Discrete variables are expressed as propor-
tions (percentages) and compared by the chi-square test. A
multivariable analysis (step-wise logistic regression) was
performed in order to identify independent predictors of
FWR in the study population. The multivariable analysis
included not only those variables significantly associated
with the incidence of FWR in the univariable analysis, but
also reperfusion strategy (PA or thrombolysis) and variables
that potentially could be related to the risk of FWR, such as
treatment with beta-adrenergic blocking agents, hyperten-
sion and previous AMI. Associations were considered sta-
tistically significant when p  0.05, although all p  0.10
are provided.
Abbreviations and Acronyms
AMI  acute myocardial infarction
CADILLAC  Controlled Abciximab and Device
Investigation to Lower Late Angioplasty
Complications
CI  confidence interval
FWR  free wall rupture
GUSTO  Global Use of Strategies to Open
Occluded Coronary Arteries
INTIME  Intravenous nPA for Treatment of
Infarcting Myocardium Early
OR  odds ratio
PA  primary angioplasty
PAMI  Primary Angioplasty in Myocardial
Infarction
RR  risk ratio
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RESULTS
Baseline characteristics. Baseline characteristics in both
groups are shown in Table 1. Patients treated with PA,
compared with those treated with thrombolysis, were older
and had worse Killip class; longer time from the onset of
symptoms; and higher frequency of female gender, hyper-
tension, diabetes and anterior location.
Incidence and predictors of FWR. The incidence of
FWR in the whole study population was 2.5% (n  34):
1.8% in patients treated with PA (n14) and 3.3% in those
treated with thrombolysis (n  20) (p  0.686). In patients
treated with thrombolysis, FWR was acute in 13 cases
(65.0%) and subacute in seven cases (35.0%). In those
treated with PA, FWR was acute in eight cases (57.1%) and
subacute in six cases (42.9%) (p  NS in comparison with
thrombolysis group). The diagnosis of FWR was estab-
lished by autopsy, by surgery or clinically with the help of
echocardiography in 13 (38.2%), 10 (29.4%) and 11 (32.3%)
cases, respectively.
In the univariable analysis, the following subgroups were
associated with higher rates of FWR: age 70 years (5.2%
vs. 1.2%, p  0.001), female gender (5.1% vs. 1.8%, p 
0.006), anterior location (3.3% vs. 1.4%, p  0.020) and
treatment 2 h after symptom onset (3.6% vs. 1.7%, p 
0.043) (Table 2).
In the multivariable analysis, two characteristics were
independent predictors of FWR: age 70 years (odds ratio
[OR]: 4.12; 95% confidence interval [CI]: 2.04 to 8.62; p
0.001) and anterior location (OR: 2.91; 95% CI: 1.36 to
6.63; p  0.008). Conversely, treatment with PA was
independently associated with a lower incidence of FWR
(OR: 0.46; 95% CI: 0.22 to 0.96; p  0.0371).
Primary angioplasty was associated with a lower rate of
FWR, irrespective of AMI location (risk ratio [RR]: 0.64
[95% CI: 0.27 to 1.54] in anterior AMI; RR: 0.21 [95% CI:
0.03 to 1.73] in inferior AMI) and gender (RR: 0.60 [95%
CI: 0.24 to 1.48] in men; RR: 0.66 [95% CI: 0.33 to 1.30]
in women). Primary angioplasty reduced the risk of FWR,
especially in elderly patients but not in those 70 years old or
younger (RR: 0.47 [95% CI: 0.19 to 1.17] in patients 70
years old; RR: 1.03 [95% CI: 0.32 to 3.34] in patients 70
years) (Fig. 1).
DISCUSSION
The incidence of FWR in the present series was 2.5%,
which does not differ from that of previous studies in
patients with AMI treated conservatively or with thrombol-
ysis (5,6,19). There was no statistical difference in this
incidence between patients treated with PA (1.8%) and
those treated with thrombolysis (3.3%). In the multivariate
analysis, however, PA was independently associated with
lower incidence of FWR. Therefore, the major finding of
the present study is that PA was independently associated
with a lower incidence of FWR.
Effect of successful coronary recanalization over the risk
of FWR. The reduction in the rate of FWR achieved by
PA probably resulted from the earlier and more effective
coronary recanalization. Although little is known about the
pathophysiology of FWR, there are some data suggesting
that a sustained and complete coronary occlusion might be
a necessary condition. Cheriex et al. (20) demonstrated that
Table 1. Clinical Differences Between Patients Treated With
PA or With Thrombolysis
PA
(n  762)
Thrombolysis
(n  613)
p
Value
Age (yrs) 64  13 61  12 0.0001
Male gender (%) 78.9 84.8 0.0053
Hours from symptoms onset (%) 3.3  3.1 2.9  2.7 0.0279
Hypertension (%) 45.8 36.4 0.0005
Diabetes mellitus (%) 23.6 17.7 0.0077
Previous AMI (%) 14.6 13.3 NS
AMI location (%)
Anterior 61.6 32.1 0.0001
Inferior 32.1 62.9 0.0001
Lateral 4.6 2.8 0.0742
Others 1.7 2.2 NS
Killip class  I (%) 25.6 14.6 0.0001
Beta-blockers 27.4 23.7 NS
AMI  acute myocardial infarction; PA  primary angioplasty.
Table 2. Characteristics Associated With the Risk of FWR in the Univariable Analysis
Incidence
of FWR p Value
Incidence
of FWR p Value
Age 0.001 Diabetes NS
70 yrs 5.2% Yes 1.4%
70 yrs 1.2% No 2.4%
Gender 0.006 Previous AMI NS
Male 1.8% Yes 1.6%
Female 5.1% No 2.2%
Time from onset 0.043 Anterior location 0.020
2 h 3.6% Yes 3.3%
2 h 1.7% No 1.4%
Hypertension NS Reperfusion strategy NS
Yes 2.5% PA 1.8%
No 1.9% Thrombolysis 3.3%
AMI  acute myocardial infarction; FWR  free wall rupture; PA  primary angioplasty.
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most patients with FWR identified by autopsy have com-
plete occlusion or incomplete reperfusion of the infarct-
related artery. In the study by Morishima et al. (21), patients
with severe no-reflow after PA had larger infarctions and a
higher risk of FWR. Finally, in a recent study (10), we
observed that in patients with AMI referred to PA, the
presence of a TIMI flow grade 0 at the initial angiogram is
statistically associated with higher risk of FWR.
Taking into consideration these data, an early restoration
of coronary patency should theoretically reduce the fre-
quency of FWR. In the study of Nakamura et al. (22),
patients with AMI that were reperfused had a lower
incidence of FWR compared with patients not reperfused,
especially when a successful coronary reperfusion is ob-
tained. Although contradictory data exist, thrombolytic
therapy seems not to increase the risk of FWR (23,24).
Comparison between PA and thrombolysis. Primary an-
gioplasty achieves the restoration of coronary patency more
frequently than thrombolysis (2–4). The effect of PA on the
risk of FWR, however, has not been evaluated in detail. In
most series of patients with AMI treated with PA, this
incidence is very low (0% to 0.8%), especially when a
successful angiographic result is obtained (7–9). However,
in most randomized studies comparing PA with thrombol-
ysis, the incidence of FWR has not been well studied. In the
studies by Zijlstra et al. (3), Grines et al. (2) and an
angiographic substudy of GUSTO IIb (11), the incidence of
FWR is not reported.
In our institution, there is a great awareness of the early
diagnosis and management of FWR, and every patient with
AMI and hypotension undergoes an immediate transtho-
racic echocardiogram in order to rule out FWR (10,16). In
our anterior location AMI randomized study, the incidence
of FWR was higher in patients treated with thrombolysis
than in those treated with primary percutaneous translumi-
nal coronary angioplasty (8.1% vs. 3.7%) (4). Although
these differences did not reach statistical significance, this
reduction in the risk of FWR could be important in
accounting for the lowering of mortality obtained by PA
compared with thrombolysis. We have recently reported a
frequency of FWR of 2.2% in 590 patients treated with PA,
a frequency not different from that of a series of patients
treated conservatively or with thrombolysis (10). However,
elderly patients and those with anterior location are prefer-
ably referred to PA, both factors being associated with a
higher incidence of FWR (10,25,26). To overcome this
possible selection bias, we performed a multivariable anal-
ysis that included patients with AMI treated with either PA
or thrombolysis during the same period of time. For the first
time, we have demonstrated that PA is a protective factor
for FWR compared with thrombolysis. Other factors re-
lated to the risk of FWR (advanced age, anterior location
and female gender) were similar to that of previous studies
(10,25,26).
In this study, the incidence of FWR in patients treated
with PA was slightly lower (1.8%) than that previously
reported (2.2%) (10). This could be related to a progres-
sively less restrictive criteria for referring patients to PA
(especially more patients with non-anterior location AMI),
although the influence of an improvement on the results of
PA cannot be excluded (18).
Figure 1. Effect of primary angioplasty (PA) compared with thrombolysis on the risk of free wall rupture according to age, gender and infarct location.
CI  confidence interval; OR  odds ratio.
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According to our results, the benefit given by PA seems
to be independent of AMI location and gender. Neverthe-
less, PA may be especially beneficial for patients over 70, the
risk of FWR being similar irrespective of the reperfusion
strategy applied in younger patients.
Conclusions and practical implications. In patients with
AMI that are treated with reperfusion strategies, PA inde-
pendently reduces the risk of FWR in comparison with
thrombolysis. Therefore, apart from reducing the rate of
recurrent ischemia and intracranial bleeding, there could be
another reason for preferring PA as a reperfusion strategy
for AMI.
Study limitations. This study has some limitations. First,
it is a retrospective study, and theoretically, FWR could be
present in some patients before thrombolysis or PA. The
biggest challenge of this study was to identify all cases of
FWR. However, at our institution, every patient with AMI
suffering hypotension, syncope or other hemodynamic in-
stability undergoes an immediate transthoracic echocardio-
graphic study, and the possibility that FWR was present
before PA or thrombolysis is very low. The criteria we used
to define FWR have been previously validated and demon-
strated a very high diagnostic accuracy (16). Secondly,
although the study population was large, it could be con-
sidered relatively small, taking into consideration the rela-
tively low incidence of FWR. However, the study popula-
tion was large enough to obtain a statistically significantly
lower incidence of FWR in patients treated with PA in the
multivariable analysis. Moreover, this is a non-randomized
study. However, there are not very likely to be new ran-
domized studies on PA versus thrombolysis in patients with
AMI, and available studies provide very few data about this
FWR. Finally, some authors have suggested that thrombol-
ysis could increase the risk of FWR by means of producing
more intramyocardial hemorrhage (27). So, it could be
argued that the lower incidence of FWR in patients treated
with PA compared with thrombolysis in our study could be
due partly to an increased risk in the group of patients
treated with thrombolysis. However, an increased risk of
FWR in patients treated with thrombolysis compared with
placebo has not been demonstrated (23,24).
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